Showing results (1191-1200 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|April 19, 2019
MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositisTaro Ukichi, Ken Yoshida, Satoshi Matsushima, et al.
RMD Open|April 19, 2019
Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54Rieke Alten, Bogdan Batko, Tomas Hala, et al.
RMD Open|April 1, 2022
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDsJames M Gwinnutt, Maud Wieczorek, Giulio Cavalli, et al.
RMD Open|March 17, 2022
Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trialCatherine Beauvais, Françoise Fayet, Alexandra Rousseau, et al.
RMD Open|March 17, 2022
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd studyDésirée van der Heijde, Lianne S Gensler, Walter P Maksymowych, et al.
RMD Open|March 24, 2022
Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomesIain B McInnes, Laura M Sawyer, Kristen Markus, et al.
RMD Open|March 18, 2022
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in FranceMaxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
RMD Open|March 1, 2019
Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort studyHilal Ince-Askan, Erica L T van den Akker, Yolanda B de Rijke, et al.
Pageof 192